Evidence map›Paper›PMID 36739390›Full record

ArticleBMC microbiology2023

Antibiotic resistance pattern, capsular types, and molecular characterization of invasive isolates of Streptococcus pneumoniae in the south of Tunisia from 2012 to 2018.

Sonia Ktari, Nourelhouda Ben Ayed, Imen Ben Rbeh, Nourhène Garbi, Sonda Maalej, Basma Mnif, Faouzia Rhimi, Adnene Hammami

Abstract read
In one paragraph

Article in BMC microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. The Evolution of the Antimicrobial Resistance ofAntibiotics (Basel, Switzerland) · 2025
    Article
  9. Detection of Macrolide-ResistantThe Malaysian journal of medical sciences : MJMS · 2024
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sonia KtariLaboratory of Microbiology, Faculty of Medicine Sfax, University of Sfax-Tunisia, Avenue Majida Boulila, 3027, Sfax, Tunisia. sonia_ktari2002@yahoo.fr.
Nourelhouda Ben AyedResearch Laboratory Microorganisms and Human Disease "MPH LR03SP03", Sfax, Tunisia.
Imen Ben RbehResearch Laboratory Microorganisms and Human Disease "MPH LR03SP03", Sfax, Tunisia.
Nourhène GarbiMedical Genetic Department, HediChaker Hospital, Sfax, Tunisia.
Sonda MaalejResearch Laboratory Microorganisms and Human Disease "MPH LR03SP03", Sfax, Tunisia.
Basma MnifResearch Laboratory Microorganisms and Human Disease "MPH LR03SP03", Sfax, Tunisia.
Faouzia RhimiResearch Laboratory Microorganisms and Human Disease "MPH LR03SP03", Sfax, Tunisia.
Adnene HammamiLaboratory of Microbiology, Faculty of Medicine Sfax, University of Sfax-Tunisia, Avenue Majida Boulila, 3027, Sfax, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStreptococcus pneumoniae remains a leading cause of morbidity and mortality worldwide. In this study, we sought to analyze serotype distributions, antibiotic resistance, and genetic relationships of 106 clinical invasive pneumococcal isolates recovered in Tunisia between 2012 and 2018, prior to the routine use of pneumococcal conjugate vaccines (PCV).

methodsWe used multiplex PCR, the disk diffusion method and/or E-test, and multi-locus sequence typing (MLST).

resultsThe most frequent serotypes were 14 (17%), 19F (14.2%), and 3 (11.3%). Of the 106 S. pneumoniae isolates, 67.9% were penicillin non-susceptible (29.4% were resistant), 45.3% were amoxicillin non-susceptible (17% were resistant), and 16% were cefotaxime non-susceptible. For antibiotics other than β-lactams, resistance rates to erythromycin, tetracycline, cotrimoxazole, and chloramphenicol were 62.3, 33, 22.6, and 4.7%, respectively. Two isolates were non-susceptible to levofloxacin. Among 66 erythromycin-resistant pneumococci, 77.3% exhibited the cMLSB phenotype, and 87.9% carried ermB gene. All tetracycline-resistant strains harbored the tetM gene. The potential coverage by 7-, 10-, and 13-valent pneumococcal conjugate vaccines were 55.7, 57.5, and 81.1%, respectively. A multilocus sequence typing analysis revealed great diversity. Fifty different sequence types (STs) were identified. These STs were assigned to 10 clonal complexes and 32 singletons. The most common STs were 179, 2918, 386, and 3772 - related mainly to 19F, 14, 6B/C, and 19A serotypes, respectively.

conclusionsThis study demonstrated that the majority of the serotypes of invasive pneumococci in the Tunisian population were 14, 19F, and 3. Moreover, we noted a high degree of genetic diversity among invasive S. pneumoniae isolates. The highest proportions of antibiotic non-susceptible isolates were for penicillin, erythromycin, and tetracycline. Further molecular characteristics are required to monitor the genetic variations and to follow the emergence of resistant pneumococci for the post-vaccination era in Tunisia.

Indexed as

Pneumococcal InfectionsStreptococcus pneumoniaeAnti-Bacterial AgentsDrug Resistance, MicrobialErythromycinHumansMicrobial Sensitivity TestsMultilocus Sequence TypingPenicillinsPneumococcal VaccinesSerogroupTetracyclineTunisiaAnti-Bacterial AgentsErythromycinPenicillinsPneumococcal VaccinesTetracyclineAntibiotic resistanceClonal complexInvasive pneumococcal diseaseMLSTSerotype

Identifiers

PMID36739390
PMCPMC9898894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.